Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study. | Eur J Cancer | 2025 | 40466468 | PubTator, text mining | PubMed |
| DPYD Genotyping, Fluoropyrimidine Dosage and Toxicity: An Umbrella Review of Systematic Reviews. | Pharmaceuticals (Basel) | 2025 | 40430545 | PubTator, text mining | PubMed |
| Pharmacogenetic Profiling of Genes Associated with Outcomes of Chemotherapy in Omani Healthy Controls. | Genes (Basel) | 2025 | 40428413 | PubTator, text mining | PubMed |
| Plasma Metabolic Outliers Identified in Estonian Human Knockouts. | Metabolites | 2025 | 40422899 | PubTator, text mining | PubMed |
| Opportunities amid complexities in returning genetic results to black precision medicine research participants: Interview themes in context with open all of us data. | J Clin Transl Sci | 2025 | 40395398 | PubTator, text mining | PubMed |
| Navigating challenging patient factors in systemic therapy for head and neck cancer. | Oncologist | 2025 | 40377445 | PubTator, text mining | PubMed |
| Unveiling the heritability of selected unexplored pharmacogenetic markers in the Saudi population. | Front Pharmacol | 2025 | 40376268 | PubTator, text mining | PubMed |
| Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives. | Front Genet | 2025 | 40370700 | PubTator, text mining | PubMed |
| Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patients. | Br J Clin Pharmacol | 2025 | 40289265 | PubTator, text mining | PubMed |
| Differences in DPYD Population Frequencies Observed in Galicians Compared to Europeans and Spanish from PhotoDPYD Study. | Pharmaceuticals (Basel) | 2025 | 40283950 | PubTator, text mining | PubMed |
| Liquid biopsy-derived extracellular vesicle protein biomarkers for diagnosis and prognostic assessment of lung squamous cell carcinoma. | Cancer Cell Int | 2025 | 40275246 | PubTator, text mining | PubMed |
| A Study of Sudden Cardiac Death in Schizophrenia. | Heart Lung Circ | 2025 | 40263070 | PubTator, text mining | PubMed |
| IFNα2b/5-FU inhibits proliferation and cell cycle of squamous carcinoma cell line Cal27. | Int J Ophthalmol | 2025 | 40256022 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling requires a blended ecosystem of learning healthcare and clinical trials. | Br J Cancer | 2025 | 40251279 | PubTator, text mining | PubMed |
| Pharmacogenomic analysis and clinical annotation of 635 patients. | Per Med | 2025 | 40247430 | PubTator, text mining | PubMed |
| Predictive biomarkers and molecular subtypes in DLBCL: insights from PCD gene expression and machine learning. | Discov Oncol | 2025 | 40240734 | PubTator, text mining | PubMed |
| Balance of care activity after EMA recommendation for DPYD gene testing in Galicia. | Front Pharmacol | 2025 | 40223928 | PubTator, text mining | PubMed |
| Implementing DPYD genotyping to predict chemotherapy toxicity in Australia: a feasibility study. | Intern Med J | 2025 | 40214188 | PubTator, text mining | PubMed |
| Securing Fluoropyrimidine-based chemotherapy: comparison of three methods of screening for dihydropyrimidine dehydrogenase deficiency. | Eur Rev Med Pharmacol Sci | 2025 | 40171786 | PubTator, text mining | PubMed |
| Opportunities and Challenges of Population Pharmacogenomics. | Ann Hum Genet | 2025 | 40171627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=9